高血压影响慢性淋巴细胞白血病的生存和治疗
Noomi Vainer1, Christian Brieghel2, Klaus Rostgaard3
1The Danish Cancer Institute, Copenhagen, Denmark.
Blood advances
|January 28, 2026
概括
高血压影响慢性淋巴细胞白血病 (CLL) 的存活率,特别是在75岁以下的患者中. 管理高血压对于CLL患者的更好的结果至关重要.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 流行病学 流行病学
背景情况:
- 高血压是慢性淋巴细胞白血病 (CLL) 患者常见的并发症.
- 高血压对CLL病程和存活率的影响尚不清楚.
- 了解这种关联对于改善患者管理和结果至关重要.
研究的目的:
- 检查丹麦CLL患者高血压和生存率之间的关联.
- 为了比较患有高血压和没有高血压的CLL患者的生存结果.
- 调查高血压对CLL诊断和治疗后生存时间的影响.
主要方法:
- 全国范围的丹麦患者发生CLL的队列研究 (2008-2022年).
- 对于生存分析的Cox比例危险回归.
- 累积发病率的阿伦-约翰森估计,与一般人群进行比较.
主要成果:
- 在诊断时,CLL队列中的高血压患病率为46%.
- 高血压与CLL诊断和治疗后的总生存期 (OS) 较短有关.
- 这种关联在75岁以下的患者中是显著的.
结论:
- 高血压显著影响了CLL患者的生存率,特别是75岁以下的患者.
- 感染和心脑血管事件是死亡的主要原因.
- 保持定期的初级保健接触和预防性健康措施对于患有高血压的CLL患者至关重要.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
596
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
596
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
464
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
464
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
505
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
505
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
615
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
615
Survival Curves
702
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
702
Survival Tree
422
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
422


